BD Advances Entry into NGS with Acquisition of GenCell Biosystems

Leading medical technology company Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA) has acquired GenCell Biosystems (Limerick, Ireland), a privately-held biotech company that has developed proprietary technologies that address key biological analysis protocols —from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.

“We are excited with the GenCell Biosystems acquisition as it provides BD entry into the Next Generation Sequencing market, a fast-growing segment with the potential to have a significant impact on healthcare,” said Linda Tharby, Group President, BD, “The acquisition gives BD access to the NGS market with a differentiated platform that will provide a base to further grow our genomics offerings.”

GenCell Biosystems is an Enterprise Ireland-supported company whose headquarters and manufacturing are based in Limerick (Ireland), and operates a USA marketing, sales, and service group in Madison (WI, USA). More...